Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders.
J Invest Dermatol. 2021 Jan;141(1):72-83.e6. doi: 10.1016/j.jid.2020.05.090. Epub 2020 Jun 4.
J Invest Dermatol. 2021.
PMID: 32505549
Free PMC article.
Review.
Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders.
Veit JGS, Poumay Y, Mendes D, Kreitinger J, Walker L, Paquet A, Menigot C, Zolezzi F, Paller AS, Diaz P.
Veit JGS, et al.
Skin Health Dis. 2021 Mar 26;1(2):e22. doi: 10.1002/ski2.22. eCollection 2021 Jun.
Skin Health Dis. 2021.
PMID: 35664983
Free PMC article.
Item in Clipboard
Cite
Cite